Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly Docetaxel in Recurrent or Persistent Endometrial Carcinoma
NCT00085332Phase 2Completed
- Sponsor
- GOG Foundation
- Start
- Jul 2004
- Primary completion
- Dec 2005
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of docetaxel in endometrial carcinoma, sponsored by GOG Foundation. Started Jul 2004; status: completed.
02
Drugs
docetaxel
03
Conditions
endometrial carcinoma
Beyond the preview
Go deeper on NCT00085332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00085332.